Table 2 Patient and tumor characteristics of the 53 patients with clinical follow-up data (The numbers in parenthesis are percentages).*

Patients

10

15

7

21

   Male

39 (74)

8 (80)

10 (67)

4 (57)

17 (81)

   Female

14 (26)

2 (20)

5 (33)

3 (43)

4 (19)

Primary Tumor

   pT1

15 (28)

4 (40)

3 (20)

3 (42)

5 (24)

   pT2

8 (15)

1 (10)

2 (13)

2 (29)

3 (14)

   pT3

30 (57)

5 (50)

10 (67)

2 (29)

13 (62)

Lymph node status

   pN0

27 (51)

4 (40)

9 (60)

5 (71)

9 (43)

   pN1

26 (49)

6 (60)

6 (40)

2 (29)

12 (57)

Tumor grade

   G2

38 (72)

7 (70)

11 (73)

5 (71)

15 (71)

   G3

15 (28)

3 (30)

4 (27)

2 (29)

6 (29)